Apolipoproteins and Apolipoprotein Mimetic Peptides Modulate Phagocyte Trafficking through Chemotactic Activity

Serum Amyloid A Induces CCL2 Production via Formyl Peptide Receptor-Like 1-Mediated Signaling in Human Monocytes

(2014) H. Y. Lee et al.   JOURNAL OF IMMUNOLOGY

Effects of Liver X Receptor Agonist Treatment on Pulmonary Inflammation and Host Defense

(2014) K. Smoak et al.   JOURNAL OF IMMUNOLOGY

Apolipoprotein E and Peptide Mimetics Modulate Inflammation by Binding the SET Protein and Activating Protein Phosphatase 2A

(2011) D. J. Christensen et al.   JOURNAL OF IMMUNOLOGY

Apolipoprotein E Negatively Regulates House Dust Mite–induced Asthma via a Low-Density Lipoprotein Receptor–mediated Pathway

(2010) Xianglan Yao et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Role of Lung Apolipoprotein A-I in Idiopathic Pulmonary Fibrosis

(2010) Tae Hoon Kim et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

High-Density Lipoproteins Suppress Chemokines and Chemokine Receptors In Vitro and In Vivo

(2010) Christina A. Bursill et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Biological Properties of Apolipoprotein A-I Mimetic Peptides

(2010) Godfrey S. Getz et al.   Current Atherosclerosis Reports

Inhibition of neutrophil migration in mice by mouse formyl peptide receptors 1 and 2 dual agonist: indication of cross-desensitization in vivo

(2010) Yoshitaka Sogawa et al.   IMMUNOLOGY

5A, an Apolipoprotein A-I Mimetic Peptide, Attenuates the Induction of House Dust Mite-Induced Asthma

(2010) X. Yao et al.   JOURNAL OF IMMUNOLOGY

Cutting Edge: A Critical Role for the G Protein-Coupled Receptor mFPR2 in Airway Inflammation and Immune Responses

(2010) K. Chen et al.   JOURNAL OF IMMUNOLOGY

Genetic deletion of apolipoprotein A-I increases airway hyperresponsiveness, inflammation, and collagen deposition in the lung

(2010) Weiling Wang et al.   JOURNAL OF LIPID RESEARCH

The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats

(2010) Lijun Dai et al.   JOURNAL OF LIPID RESEARCH

Formyl Peptide Receptor 1 and 2 Dual Agonist Inhibits Human Neutrophil Chemotaxis by the Induction of Chemoattractant Receptor Cross-desensitization

(2010) Yoshitaka Sogawa et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Structure and Function of HDL Mimetics

(2009) Mohamad Navab et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The 5A Apolipoprotein A-I Mimetic Peptide Displays Antiinflammatory and Antioxidant Properties In Vivo and In Vitro

(2009) Fatiha Tabet et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune Responses

(2009) Laurent Yvan-Charvet et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

High-density lipoprotein: A potent inhibitor of inflammation

(2009) Andrew J Murphy et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils

(2009) Zhifang Zhang et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Neutrophil apoptosis: A target for enhancing the resolution of inflammation

(2009) János G. Filep et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family

(2009) R. D. Ye et al.   PHARMACOLOGICAL REVIEWS

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

(2008) LeAnne T. Bloedon et al.   JOURNAL OF LIPID RESEARCH